Next Article in Journal
Evaluation of Medication Error Incident Reports at a Tertiary Care Hospital
Previous Article in Journal
Incorporating Oral Health Considerations for Medication Management in Care Transitions
Open AccessArticle

Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease

1
Faculty of Health and Medicine, School of Biomedical Science and Pharmacy, University of Newcastle, Callaghan, New South Wales 2308, Australia
2
Priority Research Centre, Digestive Health and Neurogastroenterology, University of Newcastle, New Lambton Heights, New South Wales 2308, Australia
3
Faculty of Health and Medicine, School of Medicine and Public Health, University of Newcastle, New Lambton Heights, New South Wales 2308, Australia
*
Author to whom correspondence should be addressed.
Pharmacy 2020, 8(2), 68; https://doi.org/10.3390/pharmacy8020068
Received: 17 March 2020 / Revised: 12 April 2020 / Accepted: 15 April 2020 / Published: 17 April 2020
Background and aim: Managing patients with a chronic condition such as inflammatory bowel disease (IBD), requires a multidiscipline approach. The pharmacist might be the first point of contact for patients with initial symptoms or relapsing flares, yet there is no available literature on the role of pharmacists in IBD management. We conducted a survey to explore pharmacists’ confidence in and potential barriers to managing IBD and assess the impact of IBD education on their confidence in IBD management. Methods: Surveys assessing confidence levels in managing IBD, additional learning opportunities about IBD and barriers to their learning of IBD management were provided to pharmacists for completion before and after attending an IBD-specific education session at a national conference. Results: Of the 195 attendees, 125 participants completed the survey (64%). Most respondents reported a low to mid-range level of confidence with managing IBD. Specifically, they were only slightly confident in decision making on patient care, addressing patient needs and providing additional support for IBD patients; and somewhat confident with understanding, management and providing relevant information on IBD. Whist the education session improved pharmacists perceived level of confidence, most respondents indicated a need to learn more about IBD. Areas of additional learning included science, drug therapy, treatments (includes non-pharmacological options as well) and guidelines. A majority of pharmacists identified time constraints as a key barrier to learning. Conclusion: Pharmacists lack sufficient confidence about managing inflammatory bowel disease. These data indicate support within the pharmacy profession to play a more active role in the management of IBD. View Full-Text
Keywords: cross-sectional survey; continuing education; pharmacy practice; inflammatory bowel disease; pharmacist; professional cross-sectional survey; continuing education; pharmacy practice; inflammatory bowel disease; pharmacist; professional
Show Figures

Graphical abstract

MDPI and ACS Style

Prasad, S.S.; Keely, S.; Talley, N.J.; Kairuz, T.; Walker, M.M. Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease. Pharmacy 2020, 8, 68.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop